1. Home
  2. GLMD vs NAAS Comparison

GLMD vs NAAS Comparison

Compare GLMD & NAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLMD
  • NAAS
  • Stock Information
  • Founded
  • GLMD 2000
  • NAAS 2019
  • Country
  • GLMD Israel
  • NAAS China
  • Employees
  • GLMD N/A
  • NAAS N/A
  • Industry
  • GLMD Biotechnology: Pharmaceutical Preparations
  • NAAS Other Specialty Stores
  • Sector
  • GLMD Health Care
  • NAAS Consumer Discretionary
  • Exchange
  • GLMD Nasdaq
  • NAAS Nasdaq
  • Market Cap
  • GLMD 7.5M
  • NAAS 8.3M
  • IPO Year
  • GLMD 2014
  • NAAS 2017
  • Fundamental
  • Price
  • GLMD $1.48
  • NAAS $3.50
  • Analyst Decision
  • GLMD Hold
  • NAAS
  • Analyst Count
  • GLMD 1
  • NAAS 0
  • Target Price
  • GLMD N/A
  • NAAS N/A
  • AVG Volume (30 Days)
  • GLMD 213.6K
  • NAAS 126.3K
  • Earning Date
  • GLMD 11-13-2025
  • NAAS 09-05-2025
  • Dividend Yield
  • GLMD N/A
  • NAAS N/A
  • EPS Growth
  • GLMD N/A
  • NAAS N/A
  • EPS
  • GLMD N/A
  • NAAS N/A
  • Revenue
  • GLMD N/A
  • NAAS $27,534,354.00
  • Revenue This Year
  • GLMD N/A
  • NAAS $378.49
  • Revenue Next Year
  • GLMD N/A
  • NAAS N/A
  • P/E Ratio
  • GLMD N/A
  • NAAS N/A
  • Revenue Growth
  • GLMD N/A
  • NAAS N/A
  • 52 Week Low
  • GLMD $1.15
  • NAAS $1.96
  • 52 Week High
  • GLMD $23.80
  • NAAS $74.40
  • Technical
  • Relative Strength Index (RSI)
  • GLMD 51.13
  • NAAS 60.58
  • Support Level
  • GLMD $1.33
  • NAAS $2.69
  • Resistance Level
  • GLMD $1.60
  • NAAS $3.33
  • Average True Range (ATR)
  • GLMD 0.10
  • NAAS 0.29
  • MACD
  • GLMD 0.03
  • NAAS 0.03
  • Stochastic Oscillator
  • GLMD 66.67
  • NAAS 69.83

About GLMD Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.

About NAAS NaaS Technology Inc.

Naas Technology Inc is an electric vehicle charging service provider in China, whose vision is to power the world with carbon-neutral energy. It offers an integrated set of online solutions to charging station operators. wide range of offline services that simplify the daily operations of charging station operators, and of non-charging services such as food and beverage services to station operators.

Share on Social Networks: